Jubilant Life Sciences recieves approval for anti-depressant Paxil
Jubilant Life Sciences Ltd has received final approval from USFDA for its generic version of anti-depressant Paxil tablets. The final approval for the abbreviated new […]
Approvals
Aurobindo Pharma recieves approval for Famotidine
Aurobindo Pharma Ltd has received final approval from USFDA to manufacture and market Famotidine Tablets used for acid reflux treatment. The approval has been granted […]
Glenmark Pharma recieves USFDA approval for Zyvox
Glenmark Pharmaceuticals has received the USFDA final approval for its anti-bacterial drug Zyvox. The product is the therapeutic equivalent of Zyvox tablets, 600 mg of […]
Granules India completes inspection formalities for its Vizag and Jeedimetla plants
Granules India Ltd has completed inspection formalities for USFDA inspections in its Vizag plant in Andhra Pradesh. It has not received any observation, while its […]
Granules India receives USFDA approval for Ibuprofen
Granules India has received approval from the USFDA to market generic Ibuprofen tablets in US markets. The Hyderabad-based company said US FDA has approved its […]
Biocon acquires Acacia Lifesciences
Biocon has acquired a manufacturing unit of Acacia Lifesciences in Vizag for an undisclosed amount. The company has acquired business assets of the pharmaceutical manufacturing […]
Aurobindo Pharma receives approval for Tramadol Hcl
Aurobindo Pharma has received USFDA approval for the drug Tramadol Hydrochloride extended-release tablets, which is used for treating pain for extended period in adults. The […]
Aurobindo Pharma receives USFDA approval for Telmisartan
Aurobindo Pharma has approval from USFDA for the generic drug Telmisartan used in treatment for hypertension. The company has received approval to manufacture and market […]
Aurobindo Pharma receives USFDA approval for Raloxifene Hydrochloride
Aurobindo Pharma has received the final approval from USFDA for Raloxifene Hydrochloride tablets, which is bio-equivalent and therapeutic equivalent to the reference listed drug product […]
Lupin receives USFDA approval for Omeprazole delayed-release capsules 40 mg
Lupin has received final approval from USFDA for its Omeprazole delayed-release capsules 40 mg which is market equivalent of AstraZeneca Prilosec delayed-release capsules 40mg. The […]